“A Cost-Effectiveness Study of Sequential Therapy Using Levofloxacin Versus Cefuroxime in the Treatment of Moderate Risk Community-Acquired Pneumonia (ATS III) in Adults”, Acta Med Philipp, vol. 43, no. 3, Jan. 2009, doi: 10.47895/amp.v43i3.2677.